JPH11279061A - Antipruritic solution - Google Patents

Antipruritic solution

Info

Publication number
JPH11279061A
JPH11279061A JP10083986A JP8398698A JPH11279061A JP H11279061 A JPH11279061 A JP H11279061A JP 10083986 A JP10083986 A JP 10083986A JP 8398698 A JP8398698 A JP 8398698A JP H11279061 A JPH11279061 A JP H11279061A
Authority
JP
Japan
Prior art keywords
solution
menthol
antipruritic
preparation
chlorpheniramine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10083986A
Other languages
Japanese (ja)
Inventor
Kimiko Sugita
喜美子 杉田
Tomoko Uchiyama
智子 内山
Hitomi Hori
ひとみ 堀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP10083986A priority Critical patent/JPH11279061A/en
Publication of JPH11279061A publication Critical patent/JPH11279061A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an antipruritic solution which gives excellent refreshing feeling and decreased irritation to skin by blending a specific antipruritic component with a preparation containing a high concentration of menthol to prepare the solution. SOLUTION: This solution comprises (A) menthol of 3 w/v% or more based on the whole preparation, (B) chloropheniramine or its salt (preferably chlorpheniramine meleate) and (C) water of 20-45 w/v% based on the whole preparation. Further, the component B is preferably blended in an amount of 0.01-2 w/v% based on the whole preparation in terms of the amount of chlorpheniramine. For example, the solution is obtained by dissolving 0.3 g of chlorpheniramine meleate and 3.5 g of d,1-menthol into about 40 ml of ethanol, adding 40 g of purified water and adjusting the total volume to 100 ml by adding ethanol. By this process, the antipruritic solution which gives improved refreshing feeling and causes no stimulation can be provided and the use as a medicine or the like is expectable.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は鎮痒液剤に関し、さ
らに詳しくは清涼感が向上し、かつ、皮膚刺激を抑えた
鎮痒液剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antipruritic solution, and more particularly, to an antipruritic solution having improved refreshing feeling and reduced skin irritation.

【0002】[0002]

【従来の技術】従来、虫さされなどのかゆみ止めとして
種々の外用製剤が販売されており、通常、鎮痒成分とし
てジフェンヒドラミン、塩酸イソチベンジルなどの抗ヒ
スタミン薬が配合される。それらの製剤の剤型は、液剤
またはゲル剤が一般的であるが、ゲル剤は塗布後のべた
付き感などがあり、使用感の点では液剤の方が好まし
い。また、そのような製剤は夏場に使うことが多いた
め、使用感を良くし、製品性の向上を図ることから使用
時の清涼感を増加させる必要がある。
2. Description of the Related Art Conventionally, various external preparations have been marketed as an antipruritic for insect bites and the like. Usually, antihistamines such as diphenhydramine and isothibenzyl hydrochloride are compounded as antipruritic components. The dosage form of these preparations is generally a liquid preparation or a gel preparation, but the gel preparation has a sticky feeling after application, and the liquid preparation is more preferable in terms of usability. In addition, since such preparations are often used in the summer, it is necessary to increase the refreshing sensation at the time of use in order to improve the feeling of use and improve the product properties.

【0003】一般的に外用剤に用いる清涼化剤としては
メントール、カンフル、サリチル酸メチルなどが知られ
ている。それらの清涼化剤は塗布数分以降に持続する清
涼感に大きく関与している。
[0003] Generally, menthol, camphor, methyl salicylate and the like are known as cooling agents used for external preparations. These cooling agents are significantly involved in the refreshing sensation that persists after several minutes of application.

【0004】[0004]

【発明が解決しようとする課題】本発明者らは鎮痒液剤
の清涼感向上のために、種々の清涼化剤について検討を
行ったところ、カンフルは塗布したときの熱感が生じる
ため使用感が好ましくなく、サリチル酸メチルは増量す
ると特異なにおいのため製品性の低下を招くことがわか
った。したがって、清涼感向上のために用いる清涼化剤
としてはメントールが最も好ましい。
DISCLOSURE OF THE INVENTION The present inventors have studied various refreshing agents to improve the refreshing feeling of an antipruritic solution. Undesirably, it was found that increasing the amount of methyl salicylate causes a reduction in product properties due to a specific odor. Therefore, menthol is most preferred as a cooling agent used for improving the refreshing feeling.

【0005】従来は清涼感を得るために配合するメント
ールの量が少量であっても、他の清涼化剤をさらに配合
することにより清涼感を補っていた。しかし、刺激感や
灼熱感のため製剤全体としての使用感を損なうことがあ
った。
Conventionally, even if the amount of menthol to be added to obtain a refreshing feeling is small, the refreshing feeling has been supplemented by further adding another cooling agent. However, the feeling of use as the whole preparation may be impaired due to the irritating feeling and burning sensation.

【0006】一方、液剤の場合は清涼感向上のためにメ
ントールの配合量を増加すると、塗布した際に皮膚刺激
が生じることがあることを見出した。
On the other hand, it has been found that in the case of a liquid preparation, if the amount of menthol is increased in order to improve the refreshing feeling, skin irritation may occur when applied.

【0007】本発明の目的は清涼感を向上し、かつ、皮
膚刺激が低減した鎮痒液剤を得ることにある。
An object of the present invention is to provide an antipruritic solution which improves the refreshing sensation and reduces skin irritation.

【0008】[0008]

【課題を解決するための手段】本発明者らは種々検討し
た結果、高濃度のメントールを配合した製剤に、鎮痒成
分としてクロルフェニラミンを配合し液剤とすると、清
涼感に優れ、かつ、低刺激の鎮痒液剤となることを見出
し本発明を完成した。
As a result of various studies, the present inventors have found that, when a liquid preparation is prepared by adding chlorpheniramine as an antipruritic component to a preparation containing a high concentration of menthol, a refreshing feeling and a low refreshing feeling can be obtained. The present invention was found to be a stimulant antipruritic solution and completed the present invention.

【0009】すなわち本発明はA)製剤全体の3W/V%
以上のメントール、B)クロルフェニラミンまたはその
塩、および(C)製剤全体の20〜45W/V%の水、か
らなる鎮痒液剤である。
That is, the present invention relates to A) 3 W / V% of the whole preparation
An antipruritic solution comprising the above menthol, B) chlorpheniramine or a salt thereof, and (C) water of 20 to 45 W / V% of the whole preparation.

【0010】[0010]

【発明の実施の形態】本発明においてメントールとはdl
-メントールまたはl-メントールのことである。本発明
においてはメントールの配合量は製剤全体の3W/V%以
上配合する必要がある。3W/V%未満の配合量であると
清涼感が十分でないからである。
DESCRIPTION OF THE PREFERRED EMBODIMENTS In the present invention, menthol is dl
-Menthol or l-menthol. In the present invention, the amount of menthol must be 3 W / V% or more of the whole preparation. If the amount is less than 3 W / V%, the refreshing feeling is not sufficient.

【0011】本発明でクロルフェニラミンの塩とは、医
薬品として許容される酸との塩であり、最も好ましいも
のとしてマレイン酸クロルフェニラミンがあげられる。
In the present invention, the salt of chlorpheniramine is a salt with a pharmaceutically acceptable acid, most preferably chlorpheniramine maleate.

【0012】本発明でのクロルフェニラミンまたはその
塩の配合量は、クロルフェニラミンの量に換算して製剤
全体の0.01〜2W/V%が好ましい。
The amount of chlorpheniramine or a salt thereof in the present invention is preferably 0.01 to 2 W / V% of the whole preparation in terms of the amount of chlorpheniramine.

【0013】本発明の液剤は、塗布時に液状の剤型、例
えば液剤、ローション剤、乳液剤、エアゾール剤などで
ある必要がある。ゲル、軟膏などのゼリー状の剤型は、
塗布後にべたつくなど使用感の点で好ましくないからで
ある。
The liquid preparation of the present invention must be in a liquid form at the time of application, for example, a liquid preparation, a lotion preparation, an emulsion preparation, an aerosol preparation and the like. Jelly-like dosage forms such as gels and ointments
This is because it is not preferable in terms of usability such as stickiness after coating.

【0014】本発明の液剤は、清涼感の点で製剤中に水
を配合する必要がある。そのときの水の配合量は20〜
45W/V%が好ましい。20W/V%未満であると、清涼感
が十分得られず、45W/V%を越えて配合すると、配合
成分の溶解度が低下することから製剤を製造しにくくな
るからである。
In the liquid preparation of the present invention, it is necessary to mix water in the preparation from the viewpoint of refreshing feeling. The amount of water at that time is 20-
45 W / V% is preferred. If the content is less than 20 W / V%, a refreshing feeling cannot be sufficiently obtained, and if the content is more than 45 W / V%, the solubility of the blended components is reduced, so that it becomes difficult to produce a preparation.

【0015】本発明の液剤は、液剤に一般的に使用され
る成分などを配合して通常の製法により製造することが
できる。
The liquid preparation of the present invention can be produced by a usual production method by blending components generally used in the liquid preparation.

【0016】[0016]

【発明の効果】本発明により清涼感が向上し、かつ、刺
激が生じない鎮痒液剤を得ることが可能になったので、
医薬品などに使用することができる。
EFFECT OF THE INVENTION The present invention makes it possible to obtain an antipruritic solution which improves the refreshing sensation and does not cause irritation.
It can be used for medicines and the like.

【0017】[0017]

【実施例】以下、実施例および試験例により本発明をさ
らに詳細に説明する。
The present invention will be described in more detail with reference to the following Examples and Test Examples.

【0018】実施例1Embodiment 1

【0019】[0019]

【表1】 マレイン酸クロルフェニラミン 0.3g dl-メントール 3.5g 精製水 40g エタノール 全100ml マレイン酸クロルフェニラミンおよびdl-メントールを
エタノール約40mlに溶解した。精製水を加え、エタノ
ールで全量を100mlにして液剤を得た。
Table 1 Chlorpheniramine maleate 0.3 g dl-menthol 3.5 g Purified water 40 g ethanol Total 100 ml Chlorpheniramine maleate and dl-menthol were dissolved in about 40 ml of ethanol. Purified water was added, and the total volume was adjusted to 100 ml with ethanol to obtain a liquid preparation.

【0020】比較例1 実施例1のマレイン酸クロルフェニラミンを塩酸ジフェ
ンヒドラミン2g(実施例1と同程度の鎮痒効果)に変
更した処方で、実施例1と同様にして比較用液剤を得
た。
Comparative Example 1 A liquid formulation for comparison was obtained in the same manner as in Example 1 except that chlorpheniramine maleate of Example 1 was changed to 2 g of diphenhydramine hydrochloride (an antipruritic effect similar to that of Example 1).

【0021】試験例1 実施例1および比較例1で得られた液剤について、Drai
z法(「新しい皮膚の生理と安全性」清至書院、176
頁)により皮膚一次刺激性の評価をした。被験動物とし
て日本白色兎を用い各液剤ごとに3匹で試験した。各被
験動物ごとに一次刺激性インデックス(P.I.I.)を求
め、3匹の平均を各液剤のP.I.I.値とした。
Test Example 1 The liquid preparations obtained in Example 1 and Comparative Example 1
z method ("New skin physiology and safety", Seiji Shoin, 176
P.) Was evaluated for primary skin irritation. Japanese white rabbits were used as test animals, and the test was performed with three of each liquid. The primary irritability index (PII) was determined for each test animal, and the average of the three animals was used as the PII value of each solution.

【0022】その結果、実施例1の液剤は0.5であ
り、比較例1の液剤は3.0であった。
As a result, the liquid preparation of Example 1 was 0.5, and the liquid preparation of Comparative Example 1 was 3.0.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】A)製剤全体の3W/V%以上のメントー
ル、B)クロルフェニラミンまたはその塩、および
(C)製剤全体の20〜45W/V%の水、からなる鎮痒
液剤。
1. An antipruritic liquid comprising: A) menthol of 3 W / V% or more of the whole preparation; B) chlorpheniramine or a salt thereof; and (C) 20 to 45 W / V% of water of the whole preparation.
【請求項2】製剤全体の3W/V%以上のメントール、マ
レイン酸クロルフェニラミン、および製剤全体の20〜
45W/V%の水、からなる鎮痒液剤。
(2) menthol, chlorpheniramine maleate of 3 W / V% or more of the whole preparation, and 20 to 30% of the whole preparation;
An antipruritic solution comprising 45 W / V% water.
JP10083986A 1998-03-30 1998-03-30 Antipruritic solution Pending JPH11279061A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10083986A JPH11279061A (en) 1998-03-30 1998-03-30 Antipruritic solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10083986A JPH11279061A (en) 1998-03-30 1998-03-30 Antipruritic solution

Publications (1)

Publication Number Publication Date
JPH11279061A true JPH11279061A (en) 1999-10-12

Family

ID=13817868

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10083986A Pending JPH11279061A (en) 1998-03-30 1998-03-30 Antipruritic solution

Country Status (1)

Country Link
JP (1) JPH11279061A (en)

Similar Documents

Publication Publication Date Title
US5990100A (en) Composition and method for treatment of psoriasis
JP2003183157A (en) Ophthalmologic composition
NZ197882A (en) Antiherpetically active lipstick
JPH09506865A (en) New composition
JP2000327557A (en) Emulsified composition
JPH0347252B2 (en)
JP2003505419A (en) Ophthalmic composition containing ketotifen
JPH0463852B2 (en)
JP2002212107A (en) Topical application composition
JP3608209B2 (en) Crotamiton combination external preparation
JPS6241645B2 (en)
JP3899267B2 (en) Use of tosylchloramide to treat skin, mucous membrane, organ or tissue disorders
JPS6169721A (en) Antimycotic composition
JP2000198719A (en) Hair growing agent
JP2002114711A (en) External preparation composition
JPH11279061A (en) Antipruritic solution
JP2003055193A (en) Refrigerant-containing gel-like external preparation
JP2003206224A (en) External composition
JP2003171204A (en) Gel-like insect repellent formulation
JPH0137370B2 (en)
JP2675111B2 (en) Minoxidil gel
JP2001163777A (en) Skin lotion
JPH07126159A (en) Emulsion ointment
JPH07126191A (en) Cream agent
JPH05229949A (en) Salicylic acid-blended preparation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050304

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090331